{rfName}
De

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Martinez-Lopez JAuthorOriol AAuthorSarra JAuthor

Share

Publications
>
Article

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma

Publicated to:Blood. 137 (1): 49-60 - 2021-01-07 137(1), DOI: 10.1182/blood.2020006731

Authors: Goicoechea, I; Puig, N; Cedena, MT; Burgos, L; Cordón, L; Vidriales, MB; Flores-Montero, J; Gutierrez, N; Calasanz, MJ; Ramos, MLM; Lara-Astiaso, D; Vilas-Zornoza, A; Alignani, D; Rodriguez, I; Sarvide, S; Alameda, D; Garcés, JJ; Rodríguez, S; Fresquet, V; Celay, J; Garcia-Sanz, R; Martinez-Lopez, J; Oriol, A; Rios, R; Martin-Sanchez, J; Martinez-Martinez, R; Sarra, J; Hernandez, MT; de la Rubia, J; Krsnik, I; Moraleda, JM; Palomera, L; Bargay, J; Martinez-Climent, JA; Orfao, A; Rosiñol, L; Mateos, MV; Lahuerta, JJ; Bladé, J; San Miguel, J; Paiva, B

Affiliations

Cancer Research Center - Author
Centro de Investigacion Medica Aplicada - Author
Complejo Hospitalario Universitario de Granada - Author
Cytometry Service (NUCLEUS) - Author
Hospital Clinic Barcelona - Author
Hospital Clinico San Carlos de Madrid - Author
Hospital Clínico Universitario de Salamanca - Author
Hospital Clínico Universitario Lozano Blesa - Author
Hospital Duran i Reynals - Author
Hospital Universitari I Politècnic la Fe - Author
Hospital Universitari Son Llàtzer - Author
Hospital Universitario 12 de octubre - Author
Hospital Universitario de Canarias - Author
Hospital Universitario Puerta de Hierro - Author
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO - Author
Hospital Virgen de la Arrixaca - Author
Institut Català d’Oncologia i Institut Josep Carreras - Author
Instituto de Salud Carlos III - Author
Universidad de Salamanca - Author
Universitat de Valencia, Facultad de Medicina y Odontologia - Author
‎ Catholic Univ Valencia, Sch Med & Dent, Valencia, Spain - Author
‎ Clin Univ Navarra, Ctr Invest Med Aplicada CIMA, Inst Invest Sanitaria Navarra IDISNA, Ctr Invest Biomed Red Canc CIBER ONC CB16 12 0036, Pamplona, Spain - Author
‎ Hosp 12 Octubre, CIBER ONC CB16 12 00369, Madrid, Spain - Author
‎ Hosp Clin Lozano Blesa, Zaragoza, Spain - Author
‎ Hosp Duran & Reynals, Inst Catala Oncol ICO Hosp, Barcelona, Spain - Author
‎ Hosp Puerta Hierro, Madrid, Spain - Author
‎ Hosp Son Latzer, Palma De Mallorca, Spain - Author
‎ Hosp Univ & Politecn La Fe, Valencia, Spain - Author
‎ Hosp Univ Canarias, Santa Cruz de Tenerife, Spain - Author
‎ Hosp Univ San Carlos, Madrid, Spain - Author
‎ Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, CSIC, CIBERONC C816 12 00480, Seville, Spain - Author
‎ Hosp Virgen Arrixaca, Murcia, Spain - Author
‎ Hosp Virgen de las Nieves, Granada, Spain - Author
‎ Inst Carlos III, CIBER ONC C816 12 00284, Madrid, Spain - Author
‎ Inst Carlos III, CIBER ONC CB16 12 00400, Madrid, Spain - Author
‎ Inst Catale Oncol, Badalona, Spain - Author
‎ Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Barcelona, Spain - Author
‎ Inst Josep Carreras, Badalona, Spain - Author
‎ Univ Salamanca, Canc Res Ctr, IBMCC CSIC USAL IBSAL, Salamanca, Spain - Author
‎ Univ Salamanca, Cytometry Serv NUCLEUS, Salamanca, Spain - Author
‎ Univ Salamanca, Dept Med, Salamanca, Spain - Author
‎ Univ Salamanca, Hosp Univ Salamanca,CIBER ONC CB16 12 00233, Inst Invest Biomed Salamanca IBSAL,Consejo Super, Ctr Invest Canc,Inst Biol Mol & Celular Canc IBMC, Salamanca, Spain - Author
See more

Abstract

Keywords

BortezomibCellsExpressionFlowInductionInhibitor resistanceMinimal residual diseaseModulationMultiple-myelomaSurvival

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Blood due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 2/78, thus managing to position itself as a Q1 (Primer Cuartil), in the category Hematology. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 5.84. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 5.78 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 38.57 (source consulted: Dimensions Jun 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-06-26, the following number of citations:

  • WoS: 86
  • Scopus: 104
  • Europe PMC: 44

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-26:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 120.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 120 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 26.03.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 17 (Altmetric).
  • The number of mentions in news outlets: 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Granada; United States of America.